Related Experiment Video
Updated: Apr 15, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Quantitative proteomics analysis of platelet-derived microparticles reveals distinct protein signatures when
Marco Milioli1, Maria Ibáñez-Vea2, Simone Sidoli2
1Department of Chemistry, University of Parma, 43124 Parma, Italy.
Abstract:
Platelet-derived MPs (PMPs) are a heterogeneous population of microvesicles released from platelets upon activation and apoptosis. Different platelet activations may affect PMP protein profiles and roles in intercellular communication. Here, we performed a quantitative proteomics study to characterize the protein content of PMPs generated by four differentially activated platelet samples. We selected known physiological agonists for platelet activation such as ADP, thrombin and collagen. Thrombin, which is mostly used to generate PMPs in vitro, was set as control. Platelets were activated by following a known agonist strength scale in which ADP was the weakest activation and thrombin and collagen stimulations were the strongest ones. Our proteomic analysis allowed the quantification of 3383 proteins, of which 428 membrane and 131 soluble proteins were found as significantly different in at least one of the analyzed conditions. Activation with stronger agonists led to the enrichment of proteins related to platelet activation in PMPs. In addition, proteins involved in platelet degranulation and proteins from the electron transport chain were less abundant in PMPs when stronger activation was used. Collectively, our data describe the most detailed characterization of PMPs after platelet physiological activation. Furthermore, we show that PMP protein content is highly dependent on the type of physiological agonist involved in platelet stimulation.
Biological Significance:
Platelet-derived MPs (PMPs) are a population of vesicles generated upon platelet activation by various stimuli known to be involved in several physiological and pathological processes. This manuscript investigates the protein profile of PMPs obtained by performing four different activation protocols using mass spectrometry-based quantitative proteomics. By following a known physiological agonist strength scale our findings suggest a biological link between agonist strength and proteins associated to platelet mediated processes such as activation and degranulation. These data may provide new insights for understanding PMP biological role and formation.
Insights
Platelet-derived microvesicles (PMPs) change their protein content based on how platelets are activated. Stronger platelet activation results in PMPs with proteins linked to activation, not degranulation.
Area of Science:
- Biochemistry
- Cell Biology
- Proteomics
Background:
- Platelet-derived microvesicles (PMPs) are released from activated or apoptotic platelets.
- PMPs play roles in intercellular communication, but their protein composition varies with platelet activation.
- Understanding PMP protein profiles is crucial for deciphering their biological functions.
Purpose of the Study:
- To quantitatively characterize the protein content of PMPs generated by platelets activated with different physiological agonists.
- To investigate how varying agonist strengths influence PMP protein composition and potential functions.
Main Methods:
- Quantitative proteomics was employed to analyze PMPs from platelets activated by ADP, thrombin, and collagen.
- Platelet activation was performed according to a defined agonist strength scale.
- Proteomic analysis identified and quantified proteins within the PMPs.
Main Results:
- A total of 3383 proteins were quantified, with 428 membrane and 131 soluble proteins showing significant differences across conditions.
- Stronger platelet activation led to an enrichment of proteins associated with platelet activation pathways in PMPs.
- Conversely, proteins involved in platelet degranulation and the electron transport chain were less abundant in PMPs from strongly activated platelets.
Conclusions:
- PMP protein content is significantly dependent on the type and strength of the physiological agonist used for platelet stimulation.
- These findings suggest a direct link between agonist strength and the proteins mediating platelet-mediated processes.
- This detailed characterization provides new insights into PMP formation and their biological roles in physiological and pathological contexts.
More Related Videos
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:32A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019